ArticleBMC medical imaging2025
Differentiating medullary thyroid carcinoma from papillary thyroid carcinoma using ultrasound viscosity imaging: a preliminary study.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo investigate the clinical feasibility of ultrasound viscosity imaging in the differential diagnosis of medullary thyroid carcinoma (MTC), aiming to provide more precise diagnostic tools and to support optimized treatment decisions and personalized clinical management in clinical practice.
methodsThe study included patients diagnosed with MTC and PTC (papillary thyroid carcinoma) at Shanghai Ruijin Hospital between March 2024 and December 2024. Quantitative analysis was performed for ultrasound viscosity imaging of thyroid carcinoma. Statistically significant indicators were screened and their diagnostic performance was evaluated.
resultsA total of 35 MTC patients with 35 MTC nodules and 45 PTC patients with 45 PTC nodules were finally enrolled. Various ultrasound viscosity imaging features demonstrated statistically significant value for differentiating MTC. Among them, S1-Vsd (viscosity standard deviation under the Visco mode with Shell = 1.0 mm) exhibited the best diagnostic performance with an AUC (area under the curve) of 0.70, which is superior to conventional ultrasound ACR-TIRADS (AUC = 0.63).
conclusionUltrasound viscosity imaging shows promising potential in enhancing the diagnostic accuracy of thyroid carcinoma, providing valuable support in differentiating MTC from PTC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.